Principal Financial Group
FBIO icon

Principal Financial Group’s Fortress Biotech FBIO Stock Holding History

Principal Financial Group’s Portfolio FBIO Stock Details FBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-896
Closed -$18K – 2548
2022
Q1 		$18K Buy
896
+63
+8% +$1.73K ﹤0.01% 2525
2021
Q4 		$31K Sell
833
-179
-18% -$7.98K ﹤0.01% 2499
2021
Q3 		$49K Buy
1,012
+264
+35% +$12.9K ﹤0.01% 2539
2021
Q2 		$40K Sell
748
-160
-18% -$9.65K ﹤0.01% 2584
2021
Q1 		$48K Sell
908
-143
-14% -$8.07K ﹤0.01% 2459
2020
Q4 		$50K Buy
+1,051
New +$45.5K ﹤0.01% 2395

Other funds holding FBIO

Nantahala Capital Management
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $1.1B AUM 197.64% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
OMC
Oasis Management Company Grand Cayman, Cayman Islands $1.88B AUM 54.21% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
CL
CPWM LLC Seattle, Washington $1.06B AUM 14.49% 1-Year Est. Return
PCM
Perkins Capital Management Wayzata, Minnesota $133M AUM 127.86% 1-Year Est. Return

Principal Financial Group's FBIO Position: Q2 2022 in Review

Principal Financial Group sold out of Fortress Biotech (FBIO) in Q2 2022, closing a stake of 896 shares — an estimated $18K sold.

Principal Financial Group first reported a position in FBIO in Q4 2020 and held it in 6 quarters. The position peaked at $50K in Q4 2020. 66 funds tracked by Wall St. Rank hold FBIO as of Q2 2022.

  • Principal Financial Group reported no remaining Fortress Biotech position as of Q2 2022 after selling out during the quarter.
  • Principal Financial Group sold 896 Fortress Biotech shares in Q2 2022, an estimated $18K.
  • Principal Financial Group first reported a position in Fortress Biotech in Q4 2020 and held it in 6 quarters.
  • Principal Financial Group's Fortress Biotech position peaked at $50K in Q4 2020.
  • 66 funds tracked by Wall St. Rank held Fortress Biotech as of Q2 2022.

Based on Principal Financial Group's 13F filing for Q2 2022, filed 10 Aug 2022.